HCA Healthcare Inc (NYSE:HCA) announced a quarterly dividend on Tuesday, October 30th, Zacks reports. Shareholders of record on Monday, December 3rd will be paid a dividend of 0.35 per share on Friday, December 28th. This represents a $1.40 dividend on an annualized basis and a yield of 1.04%. The ex-dividend date is Friday, November 30th.
HCA Healthcare has a dividend payout ratio of 15.2% indicating that its dividend is sufficiently covered by earnings. Analysts expect HCA Healthcare to earn $10.11 per share next year, which means the company should continue to be able to cover its $1.40 annual dividend with an expected future payout ratio of 13.8%.
Shares of HCA stock opened at $134.93 on Friday. The firm has a market cap of $46.44 billion, a price-to-earnings ratio of 20.47, a price-to-earnings-growth ratio of 1.18 and a beta of 0.48. HCA Healthcare has a 12 month low of $76.34 and a 12 month high of $144.96.
In other news, SVP Deborah M. Reiner sold 723 shares of the company’s stock in a transaction dated Monday, November 5th. The stock was sold at an average price of $135.06, for a total transaction of $97,648.38. Following the sale, the senior vice president now directly owns 6,184 shares in the company, valued at $835,211.04. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, SVP Kathryn A. Torres sold 820 shares of the company’s stock in a transaction dated Tuesday, November 13th. The shares were sold at an average price of $142.36, for a total value of $116,735.20. Following the sale, the senior vice president now owns 4,237 shares in the company, valued at $603,179.32. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 16,763 shares of company stock worth $2,346,147. Company insiders own 2.80% of the company’s stock.
HCA has been the topic of a number of analyst reports. Jefferies Financial Group lifted their price objective on shares of HCA Healthcare to $155.00 and gave the stock a “buy” rating in a report on Friday, September 21st. Leerink Swann lifted their price objective on shares of HCA Healthcare from $140.00 to $150.00 and gave the stock an “outperform” rating in a report on Tuesday, September 4th. Mizuho set a $150.00 price objective on shares of HCA Healthcare and gave the stock a “buy” rating in a report on Tuesday, September 4th. Argus boosted their price target on shares of HCA Healthcare to $150.00 and gave the stock a “buy” rating in a report on Friday, September 7th. Finally, Bank of America boosted their price target on shares of HCA Healthcare from $125.00 to $135.00 and gave the stock an “underperform” rating in a report on Tuesday, September 18th. Two investment analysts have rated the stock with a sell rating, five have assigned a hold rating and sixteen have assigned a buy rating to the company. HCA Healthcare currently has a consensus rating of “Buy” and an average price target of $144.45.
ILLEGAL ACTIVITY WARNING: This article was posted by WKRB News and is owned by of WKRB News. If you are viewing this article on another site, it was illegally copied and reposted in violation of US & international trademark & copyright law. The correct version of this article can be viewed at https://www.wkrb13.com/2018/11/25/hca-healthcare-inc-announces-quarterly-dividend-of-0-35-hca.html.
HCA Healthcare Company Profile
HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.